(OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat viral diseases, fibrosis, stroke, dementia, and Alzheimer's disease, announced its ...

This manuscript offers valuable insights by identifying two distinct liver cancer subtypes through multi-omics integration and developing a robust prognostic model, validated across various datasets, ...

Despite recent therapeutic breakthroughs, cancer patients continue to face high recurrence and mortality rates due to treatment resistance. Cancer stem cells (CSCs), a subpopulation with self-renewal ...

1MOE Key Laboratory of Gene Function and Regulation, Guangdong Province Key Laboratory of Pharmaceutical Functional Genes, School of Life Sciences, State Key Laboratory of Oncology in South China, Sun ...

Hypoxia is a common feature of solid tumors that has previously been linked to resistance to radiotherapy and chemotherapy, and more recently to immunotherapy. In particular, hypoxic tumors exclude T ...

Panel A shows worldwide age-standardized incidence and mortality rates for cervical cancer in 2022. Data are from the GLOBOCAN database and were collated by the International Agency for Research ...

JG Foster is supported by Cancer Research UK (CRUK projectgrant 12733). The hypoxia research within the group of TVS is supported by the Biotechnology and Biological Sciences Research Council ...

and hypoxia. Overall, our observations demonstrated that NCT not only induced T cell reprogramming but also extensively impacted the composition and function of B cells in the tumor microenvironment.

Evidence suggests that hypoxia and oxidative stress can control metabolic reprogramming in cancer cells and other cells within the tumor microenvironment, and reprogrammed metabolic pathways in cancer ...

MIT researchers have developed microparticles for targeted dual therapy at tumor sites, combining chemotherapy and phototherapy to reduce systemic side effects and increase effectiveness. In mouse ...